Navigation

© Zeal News Africa

Doctors Slam Kourtney Kardashian's 'Dangerous Fad' Pills Amid Public Outcry

Published 5 days ago3 minute read
Precious Eseaye
Precious Eseaye
Doctors Slam Kourtney Kardashian's 'Dangerous Fad' Pills Amid Public Outcry

Kourtney Kardashian Barker’s supplement brand, Lemme, has faced significant criticism following the launch of two new products: an "Ozempic-style" weight-loss supplement and a pill designed to reduce cellulite. These launches have drawn backlash from fans and medical professionals alike, who accuse the reality star of capitalizing on body image insecurities with unproven claims.

The controversy began with the announcement of Lemme’s "GLP-1 Daily," a supplement directly referencing the GLP-1 hormone associated with weight loss drugs like Ozempic. While the pill does not contain the key ingredients found in Ozempic, which uses a synthetic version of the GLP-1 hormone to slow digestion and dull hunger, it is marketed as a natural alternative. The brand explicitly stated it offers "a GLP-1 solution without the side effects" of the injectable drug, and Kourtney promoted an article discussing her desire to be "in on the Ozempic boom." However, experts like plastic surgeon Naveen Cavale emphasize that while Ozempic contains semaglutide, a rigorously tested GLP-1 receptor, Lemme’s product lacks this key ingredient and sufficient clinical evidence to support significant weight loss from its plant-based lemon and saffron extracts.

Similarly, Lemme launched "Lemme Smooth," a daily tablet claiming to "combat cellulite from the inside out" and reduce it in just 28 days. This product, containing French Cantaloupe Melon (SOD B Dimpless), an antioxidant, also lacks strong scientific backing according to medical experts. Mr. Cavale dismissed anti-cellulite pills as "essentially a fad and an ineffective solution to a perfectly normal condition," urging individuals to adopt a holistic approach including diet and exercise rather than relying on unproven remedies. He highlighted that cellulite is a common and natural occurrence, affecting most women, and there is no need for costly, unproven solutions.

A recurring concern for both products is the lack of evaluation by the Food and Drug Administration (FDA). Lemme’s small print reveals disclaimers stating, "This product is not intended to diagnose, treat, cure or prevent any disease." This contrasts sharply with FDA-approved products, which undergo thorough testing for efficacy and safety, providing consumers with assurance.

Critics, including plastic surgeon Naveen Cavale, have slammed Kourtney for "cashing in" on young women struggling with body image, calling the products "incredibly misleading." He warned that repeatedly using ineffective products could lead to "frustration, feelings of failure and worsened body image issues," intensifying anxiety, stress, and even depression, particularly for Gen Z customers who face societal pressure from celebrities on social media to conform to unrealistic body standards.

This isn't the first time Lemme has faced scrutiny. Since its launch in September 2022, the brand has been criticized for products like "Lemme Purr" vagina gummies, marketed to boost vaginal health and alter taste. Gynaecologist Dr. Jen Gunter vehemently criticized this product, stating, "Anyone who suggests that your vagina isn't fresh or needs an improved taste is a misogynist and awful person. And yes, that includes you Kourtney Kardashian and your Lemme grift."

Kourtney Kardashian, long known as the most health-conscious sister in the Kardashian clan, launched Lemme with the goal of creating "science-backed" vitamin and botanical supplements using "clinically-backed ingredients." She attributes her interest in wellness to the birth of her eldest son, Mason. However, the high price point of her products, with "GLP-1 Daily" costing £69 for a one-time purchase, further fuels criticism that the brand is exploiting insecurities for financial gain rather than offering genuinely effective health solutions.

Recommended Articles

Loading...

You may also like...